Trans-Pacific Partnership Deal would Likely Raise Prescription Drug Costs

The coming Trans-Pacific Partnership Trade Deal (TPP) has left many retirees concerned that their prescription drug costs will increase if a deal passes. TPP will likely limit the ability for the federal government to regulate drug prices and restrict competition from generic drugs. Moreover, “fast-track” legislation for TPP would, if passed, bring the agreement up for a vote without an opportunity to amend the agreement.
At the recent Alliance Convention in Oregon, Fiesta said, “Americans already pay the highest prescription drug prices in the world. Seniors have a huge stake in this trade deal.”
The Alliance encourages members to call their member of Congress to express their opposition to the trade deal. More from NW Labor Press at http://tinyurl.com/m334h9k